Donor Hemovigilance with Blood Donation.
نویسندگان
چکیده
BACKGROUND Reports on unexpected events (UEs) during blood donation (BD) inadequately consider the role of technical UEs. METHODS Defined local and systemic UEs were graded by severity; technical UEs were not graded. On January 1, 2008, E.B.P.S.-Logistics (EBPS) installed the UE module for plasma management software (PMS). Donor room physicians entered UEs daily into PMS. Medical directors reviewed entries quarterly. EBPS compiled data on donors, donations, and UEs from January 1, 2008 to June 30, 2011. RESULTS 6,605 UEs were observed during 166,650 BDs from 57,622 donors for a corrected incidence of 4.30% (0.66% local, 1.59% systemic, 2.04% technical UEs). 2.96% of BDs were accompanied by one UE and 0.45% by >1 UE (2-4). 6.3% of donors donating blood for their first time, 3.5% of those giving blood for their second time, and 1.9% of donors giving their third or more BD experienced UEs. Most common UEs were: discontinued collections due to venous access problems, repeated venipuncture, and small hematomas. Severe circulatory UEs occurred at a rate of 16 per 100,000 BDs. CONCLUSIONS Technical UEs were common during BD. UEs accompanied first and second donations significantly more often than subsequent donations.
منابع مشابه
Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance).
The safety of the blood supply depends on measures to protect not only the transfusion recipient but also the blood donor. Donor selection criteria have been voluntarily adopted or enforced through regulation in different countries, but review of practices in different blood centers reveals wide disparity in the current approaches. Such variability in practice suggests that the criteria for the...
متن کاملHemovigilance: a system to improve the whole transfusion chain
Hemovigilance is used to track and reduce the occurrence of adverse events associated with blood donations (1). Hemovigilance programs have now been in existence for about 20 years after being developed in 1993 in France. Although it has emerged as a tool to improve transfusion safety, many countries and centers are still in the development stage and have not yet established functioning hemovig...
متن کاملRecruitment and screening of donors and the collection, processing, and testing of blood
The blood donation and transfusion chain Although much effort has been expended to find suitable replacements for blood components, the best source continues to be blood collected from healthy, human donors. The process of supplying sufficient blood components and derivatives for patient needs is complex and highly regulated. At the same time, it must be dynamic in adapting to the local and reg...
متن کاملPresence of medication taken by blood donors in plasma for transfusion.
BACKGROUND AND OBJECTIVES The TRIP national hemovigilance and biovigilance office receives reports on side-effects and incidents associated with transfusion of labile blood products. Anaphylactic reactions accounted for the largest number of serious transfusion reactions in the period 2008-2012. In most cases, no cause is found for these reactions. TRIP data show that anaphylactic reactions occ...
متن کاملUnexpected Hypotensive Events during Preparatory Plasmaphereses.
volemic events during PP, an infusion of NaCl 0.9% 500 ml should be given during PP [3, 4]. If saline infusion was given after PP the loss of red cell mass with the tubing system could be reduced from 12,0 ml to 1,3 ml per donation on average [5]. However, the disadvantage of this method is that hypovolemic events cannot be prevented during PP. On the other hand, if 500 ml NaCl 0.9% is given st...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
دوره 42 3 شماره
صفحات -
تاریخ انتشار 2015